OncoSure Testing

10/24/2026

Understanding adverse drug effects starts with understanding the factors that can influence medication response. Pharmacogenomic testing offers insight into the role genetics may play.

Learn more about OncoSure PGx Testing.
-
-
-
-
-
-
-
-
-
-
-

10/20/2026

When a treatment plan includes multiple medications, reviewing potential drug interactions is important. Genetic factors may influence how certain drugs are processed. OncoSure PGx testing can provide additional genetic insights to support clinical decision-making.
-
-
-
-
-
-
-
-
-
-
-

10/17/2026

Life moves fast. Take a moment to slow down, breathe, and recharge.
Find your moment of calm with OncoSure. Explore more on our YouTube channel
_
-
-
-
-
-
-
-
-
-
-
-

10/13/2026

When multiple medications are part of a treatment plan, genetic insights may provide another layer of information for healthcare providers to consider. OncoSure’s Cardiovascular PGx panel helps identify relevant genetic variations that may inform medication management.
-
-
-
-
-
-
-
-
-
-
-

10/09/2026

Cancer screening has come a long way, but the approach is not the same for every cancer. OncoSure adds a blood-based multi-cancer approach designed to evaluate biomarkers associated with 200+ cancer types
-
-
-
-
-
-
-
-
-
-
-
-
OncoSure is intended to complement recommended cancer screening and is not a diagnostic test. Healthcare providers should interpret results alongside clinical evaluation.

10/06/2026

After breast cancer treatment, staying engaged with ongoing follow-up remains important. Recurrence can occur years later, which is why continued attention to changes in health matters.

OncoSure provides a minimally invasive, blood-based approach designed to evaluate biomarkers associated with 200+ cancer types, providing additional biological information over time.
-
-
-
-
-
-
-
-
-
-
-
-
OncoSure is intended to complement recommended cancer screening and is not a diagnostic test. Healthcare providers should interpret results alongside clinical evaluation.

10/05/2026

Cancer awareness is most impactful when it leads to action.

The NFL's Crucial Catch initiative highlights the importance of cancer screening, early detection, and expanding access to screening resources in communities across the country.

At OncoSure, we recognize the importance of continued progress in cancer screening and the role innovation can play alongside established screening methods.

This year’s Umbrella Cause campaign, There Is No I in Change, reinf...

10/01/2026

A proactive approach to health includes knowing your options. OncoSure Testing offers a blood-based multi-cancer screening approach designed to screen for over 200 cancer types.
-
-
-
-
-
-
-
-
-
-
-
-
OncoSure is intended to complement recommended cancer screening and is not a diagnostic test. Healthcare providers should interpret results alongside clinical evaluation.

09/29/2026

Screening gaps remain and expanding screening options is part of closing them.

OncoSure provides a minimally invasive, blood-based screening approach designed to evaluate biomarkers associated with 200+ cancer types, complementing established screening methods.
-
-
-
-
-
-
-
-
-
-
-
-
OncoSure is intended to complement recommended cancer screening and is not a diagnostic test. Healthcare providers should interpret results alongside clinical evaluation.

09/23/2026

Taking care of your health is part of taking care of the life you want to keep living.

Cancer screening is one way to stay proactive and informed about your health. OncoSure Testing offers a blood-based cancer screening option designed to complement established screening methods.
-
-
-
-
-
-
-
-
-
-
-
-
OncoSure is intended to complement recommended cancer screening and is not a diagnostic test. Healthcare providers should interpret results alongside clinical evaluation.